FDA greenlights emergency use Pfizer COVID vaccinations for young children

President Joe Biden, his administration, and most Democrats want nothing more than to be able to mandate COVID-19 vaccines for young children, and it appears as if the U.S. Food and Drug Administration (FDA) is ready to help them accomplish such goals.

According to Fox News, in a bombshell announcement this week, the FDA has approved the Pfizer-BioNTech COVID-19 vaccine for emergency use in children aged 5 to 11. 

Of course, many in the vaccine-pusher crowd have been waiting for the government agency to greenlight vaccinations for children, which has resulted in an uproar of defiance from concerned parents around the country, especially as such FDA approvals could be the final straw for some school districts to issue vaccine mandates.

The FDA on Friday released a statement in which they explained that based on “available” scientific evidence, it favored the approval of the Pfizer vaccine in emergency-use applications.

“The FDA has determined this Pfizer vaccine has met the criteria for emergency use authorization,” the agency’s statement read.

It added: “Based on the totality of scientific evidence available, the known and potential benefits of the Pfizer-BioNTech COVID-19 vaccine in individuals down to 5 years of age outweigh the known and potential risks.”

Bizarrely, acting FDA Commissioner Janet Woodcock insisted that injecting young children with the Pfizer vaccine is the path back to “normalcy” in America. “As a mother and a physician, I know that parents, caregivers, school staff, and children have been waiting for today’s authorization. Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy,” Woodcock said.

The primary difference in the children’s version of the vaccine is that it’s a lower dosage than what adults currently receive.

Sadly, millions of adults — the same one who likely rushed out to get a COVID-19 booster as soon as they were eligible — will usher their children to vaccine clinics across the country, with no real indication, other than the FDA’s “available” research, how it will ultimately affect them.